Integrated Core Strategies (US) LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-30 4:36 pm Purchase | 2025-06-27 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 471,722 5.600% | 334,820 (+244.57%) | Filing |
| 2023-01-23 4:31 pm Sale | 2022-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 136,902 2.400% | -105,365 (-43.49%) | Filing |
| 2022-07-08 4:19 pm Purchase | 2022-07-01 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 242,267 5.200% | 242,267 (New Position) | Filing |